Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA

Overview
Date Founded

2006

Headquarters

Else-Kröner-Straße 1,Bad Homburg vor der Hohe, Hessen 61352

Type of Company

Public

Employees (Worldwide)

113K

Industries

Hospitals & Patient Services

Company Description

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Contact Data
Trying to get in touch with decision makers at Fresenius Medical Care AG & Co. KGaA? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Member of the Management Board & Chief Executive Officer, Asia-Pacific

Chief Executive Officer-North America

Member of the Management Board & Chief Executive Officer for EMEA

Global Chief Medical Officer

Chief Executive Officer-Global Manufacturing & Quality

Member of the Management Board & Chief Executive Officer, Global Research & Development

Senior Vice President, Head-IR & Corporate Communications

Director, Corporate Communications

Board of Directors

Chief Executive Officer at MagForce AG

Paths to Fresenius Medical Care AG & Co. KGaA
Potential Connections via
Relationship Science
You
Fresenius Medical Care AG & Co. KGaA
Owners & Shareholders
Details Hidden

Alecta is a risk-averse manager which aims to meet the requirements of long-term pension fund management, in terms of delivering a competitive return with prudent risk management. The firm's portfolio holdings consist of approximately 50 percent fixed income, 41 percent equities, and 9 percent real estate. The core of Alecta's philosophy is a competent independent in-house analysis, focusing on the absolute return and risks of their investments. They direct their investment activities mainly to areas where the firm have such in-house capability and expertise. By limiting the number of holdings, they facilitate an even deeper analysis whereby each specific analysis can have a significant impact on the firm's performance.

Details Hidden

BNPP AM-UK is an active manager which offers a range of sustainable investment solutions including SRI strategies, environmental strategies, clean energy private equity, multi-management strategies and passive strategies. While the strategies are managed by different partner teams according to their own research and investment processes, they share a common philosophy and understanding of market demands and expectations. Their core markets are Belgium, France, Italy, Luxembourg and the Netherlands.The firm seeks to offer clients customized, value-creating solutions and aims to deliver superior risk-adjusted returns by making high-conviction investment decisions based on in-house proprietary research utilizing top-down and bottom-up approaches.BNPP AM-UK's investment teams, backed by a global operating platform and risk control framework, are encouraged to follow their convictions and are fully accountable for their investment performance and rewarded for their risk-adjusted returns.

Details Hidden

Aventicum Capital Management (Suisse) SA, part of Aventicum Capital Management Holding AG, is a company headquartered in Geneva, Switzerland. The firm provides investment advice. It was founded in 2012. Luca Mengoni is the CEO, in this role since 2013.

Recent Transactions
Details Hidden

Fresenius Medical Care AG & Co. KGaA, National Cardiovascular Partners LP purchase Cardiovascular Consultants Ltd.

Details Hidden

Fresenius Medical Care AG & Co. KGaA purchases NxStage Medical, Inc.

Details Hidden

Fresenius Medical Care AG & Co. KGaA purchases Guangzhou KangNiDaiSi Medical Investment Co., Ltd.

Transaction Advisors
Legal Advisor

Advised onFresenius Medical Care AG & Co. KGaA purchases Jiate Excelsior Co. Ltd. from Excelsior Medical Co., Ltd.

Accountant

Advised onFresenius Medical Care AG & Co. KGaA purchases Jiate Excelsior Co. Ltd. from Excelsior Medical Co., Ltd.

Legal Advisor

Advised onFresenius Medical Care AG & Co. KGaA purchases Euromedic International BV /Kidney Dialysis Ops from Affidea Group BV, Ardian SA, Montagu Private Equity LLP, Campus Holding SA, BAML Capital Partners

Attorney

Advised onFresenius Medical Care AG & Co. KGaA purchases NxStage Medical, Inc.

Legal Advisor

Advised onFresenius Medical Care AG & Co. KGaA purchases Renal Care Group, Inc.

Legal Advisor

Advised onFresenius Medical Care AG & Co. KGaA purchases Liberty Dialysis Holdings, Inc. from KRG Capital LLC, Bain Capital LP

Advisors & Consultants
Advisor

Chief Executive Officer-Asia Pacific at Fresenius Medical Care Management AG

Real Estate Agent

Vice President, Research & Development at Colliers International

Clients

DaVita is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers in 43 states in the United States, serving approximately 150,000 patients, and at 24 centers in five countries outside of the United States that serve approximately 1,000 patients.

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Key Stats and Financials As of 2018
Market Capitalization
$20.4B
Total Enterprise Value
$23.8B
Earnings Per Share
$6.47
Revenue
$16.5B
Net Profit
$1.98B
EBITDA
$3.06B
EBITDAMargin
18.5%
Total Debt
$7.55B
Total Equity
$12.9B
Enterprise Value Sales
1.44x
Enterprise Value EBITDAOperating
7.79x
TEVNet Income
12.03x
Debt TEV
0.32x
Five Year Compounded Annual Growth Rate Of Revenue
8.53%
Three Year Compounded Annual Growth Rate Of Revenue
3.13%
Investments
Details Hidden

Sound Inpatient Physicians Holdings LLC operates as a holding company. The company is headquartered in Dover, DE.

Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Co-Founder at Allos Ventures LLC

Suppliers
Vifor Pharma AG Retail: Drug Stores | St. Gallen, SG

Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It offers products for iron deficiency, nephrology, and cardio-renal therapies. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland.

Daiichi Sankyo Co Ltd. Wholesale: Consumer Non-Durables/Sundries | Tokyo, TY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

NxStage Medical, Inc. Biotechnology | Lawrence, Massachusetts

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success – is inspiring patients and providers. We’re not working alone. Part of our success has come through working closely with customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care. Our ultimate purpose is to improve the lives of renal patients, and our approach is already resulting in changed lives and industry improvements. Together, we’re changing traditional perceptions of how renal care can be delivered. NxStage innovations are expanding and improving treatment options – and giving patients and caregivers the ease and flexibility to perform treatment when they want, where they want, and how they want. We found the future of renal care because we looked for it. Thanks to forward-thinking care partners, patients, and NxStage inventors and engineers, a new era has arrived. This is great news for the estimated 2 million people around the world suffering from chronic kidney failure, or End-Stage Renal Disease (ESRD) including 571,414 in the U.S.1 It’s also good news for the hundreds of thousands of patients every year in the U.S. who suffer from acute kidney failure due to surgery, trauma, poisoning, or other emergent health situations.

Competitors
DaVita, Inc. Hospitals & Patient Services - Libertyville, IL

DaVita is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers in 43 states in the United States, serving approximately 150,000 patients, and at 24 centers in five countries outside of the United States that serve approximately 1,000 patients.

Medtronic Plc Medical Products & Equipment - Dublin, DU

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Toray Industries, Inc. Textiles - Tokyo, TY

Toray Industries Toray Group fuses nanotechnology into its operations, using organic synthetic chemistry, polymer chemistry and biotechnology as its core technologies. In addition to the Foundation Businesses of fibers & textiles and plastics & chemicals, Toray likewise promotes the global development of IT-related products, carbon fiber composite materials, pharmaceuticals and medical products, environment & engineering including water treatment and progress in other pivotal business fields.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Fresenius Medical Care AG & Co. KGaA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Fresenius Medical Care AG & Co. KGaA's profile does not indicate a business or promotional relationship of any kind between RelSci and Fresenius Medical Care AG & Co. KGaA.